Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave-Reference-Cited by-同舟云学术

Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave

Published:2022-08-31 Issue:1 Volume:11 Page:2045-2054
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Lu Guanzhu¹,Zhang Yi²,Zhang Haocheng²,Ai Jingwen²³,He Liu⁴,Yuan Xiaoling¹,Bao Suxia¹,Chen Xiaohua⁵,Wang Hongyu²,Cai Jianpeng²,Wang Sen²³,Zhang Wenhong²³,Xu Jie¹

Affiliation:

1. Department of Infectious Disease, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

2. Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, People’s Republic of China

3. Huashen Institute of Microbes and Infections, Shanghai, People’s Republic of China

4. Medical section, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

5. Department of Infectious Disease, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

Funder

National Natural Science Foundation of China

Shanghai Municipal Science and Technology Major Project

Shanghai Science and Technology Committee

Shanghai Municipal Health Commission

Infectious Disease Department and Hospital-Acquired Infection Control Department

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2022.2109517

Reference30 articles.

1. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). [assessed 2022 Jun 12]. Available from: https://www.arcgis.com/apps/opsdashboard/index.html#bda7594740fd40299423467b48e9ecf6[EB/OL]

2. Outbreak.info. [assessed 2022 May 28]. Available from: https://outbreak.info/situation-reports/omicron

3. Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages

4. Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron

5. Antibody evasion properties of SARS-CoV-2 Omicron sublineages

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver function abnormality on admission predicts long COVID syndrome in digestive system;Heliyon;2024-09

2. Omicron variant infection worsen the prognosis of haemodialysis (HD) patients;Annals of Medicine;2024-08-25

3. Real-world effectiveness and safety of nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 patients with onset of more than 5 days: a retrospective cohort study;Frontiers in Pharmacology;2024-08-19

4. Clinical real-world effectiveness of nirmatrelvir/ritonavir for the treatment of SARS-CoV-2 infection: A meta-analysis;Tungs' Medical Journal;2024-08-08

5. SARS-CoV-2 Variants and Clinical Outcomes of Special Populations: A Scoping Review of the Literature;Viruses;2024-07-30